Shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), edged down $1.08 (12.01%) to $7.91. The price of the stock ranged between a low of $7.57 and $9.74 respectively. The trading volume of 81M is above the 90 day average volume of 26M shares. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), stock opened at $9.44 in last session, and closed at $7.91, while the day range of ARIA stock is $7.57 – $9.74. The stock showed a positive weekly performance of 14.64%.
Cell Therapeutics Inc (NASDAQ:CTIC) reported that the Gynecologic Oncology Group or GOG has completed patient enrollment in the GOG-0212 Phase 3 trial of investigational agent paclitaxel poliglumex or Opaxio as maintenance therapy in ovarian cancer. Cell Therapeutics Inc (NASDAQ:CTIC), stock opened at $3.79, in last session and closed at $3.34, by losing -16.50%. The 52 week range of $0.97 – $4.25. Company’s market capitalization is $488.27million.
On January 13th, Galena Biopharma Inc (NASDAQ:GALE), announced it had acquired Mills Pharmaceuticals and the worldwide rights to GALE-401. The company announced it would pursue expedited 505(b)(2) regulatory pathway to seek approval for the treatment of Essential Thrombocythemia (ET). Galena Biopharma Inc (NASDAQ:GALE), stock decreased -11.23% and finished the last session at $5.06. The EPS of the stock remained -0.38. Company’s market capitalization is $532.50million.
Peregrine Pharmaceuticals (NASDAQ:PPHM) sank 4.98% yesterday amid news that Mr. Jeffrey L. Masten, on January 18, 2014, gave notice of resignation, effective February 20, 2014, as Vice President, Quality of Peregrine Pharmaceuticals, Inc. Peregrine Pharmaceuticals (NASDAQ:PPHM), stock opened the session at $1.83, and closed the session at $1.68. The 52 week range of the PPHM stock remained $1.11 – $2.43 and the day range was $1.66 – $1.85.
Leave a Reply